Pathophysiology of Corneal Endothelial Cell Loss in Dry Eye Disease and Other Inflammatory Ocular Disorders

Ocul Immunol Inflamm. 2023 Jan;31(1):21-31. doi: 10.1080/09273948.2021.1980808. Epub 2021 Oct 22.

Abstract

Purpose: Dry eye disease (DED) and other inflammatory ocular disorders have been reported to be associated with decreased corneal endothelial cell density (CECD), however the mechanism of underlying endothelial cell loss remains unknown.

Methods: We conducted a comprehensive literature search of English-written publications on dry eye disease, corneal endothelial cell loss, Sjögren's syndrome, and Graft Vs Host Disease (GVHD), to review the effects of DED and other inflammatory ocular surface conditions on CECD.

Results: A total of 78 studies were included in our study. Loss of corneal neurotrophic support, cytotoxic stress, and a heightened immune response, all of which may occur secondarily to a common causative agent such as inflammation, are major contributors to reduced CECD.

Conclusion: More studies are needed to determine how the interrelated pathways of altered corneal nerve function and upregulated expression of inflammatory activity influence corneal endothelial cell loss.

Keywords: Dry eye disease; Sjögren’s syndrome; corneal endothelium; graft versus host disease; ocular inflammation.

MeSH terms

  • Cornea
  • Corneal Endothelial Cell Loss
  • Dry Eye Syndromes* / etiology
  • Humans
  • Inflammation
  • Sjogren's Syndrome* / complications